Transplanting New Guidelines into Practice in Hepatorenal Syndrome and Acute Kidney Injury (HRS/AKI) – Everything is Fixed, Right?

This online course will discuss current practical evidence in differential identification of HRS/AKI versus other AKI etiologies, and proactive application of pharmacotherapy to maintain renal function, reverse HRS, and improve patient outcomes in cirrhosis and liver failure.

Supported by an educational grant from Mallinckrodt

Target Audience

  • Physicians
  • Pharmacists
  • Physician Assistants  
  • Nurse Practitioners
  • Nurses    
  • Dietitians   
  • Social Workers
  • Dialysis Technicians
  • Transplant Coordinators
Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; review the video content; complete the post-test  and evaluation to successfully earn credit.

If you participated in the live webinar Transplanting New Guidelines into Practice in Hepatorenal Syndrome and Acute Kidney Injury (HRS/AKI) – Everything is Fixed, Right? on March 26, 2020, or viewed the recording as part of the 2020 Spring Clinical Meetings from Mar 30-April 29, 2020 and claimed credit, you should not claim credit for this endured activity.

Learning Objectives

After participation in this activity, learners will be better able to:

  • Discuss current guidelines and position statements for proactively establishing diagnosis of HRS/AKI compared with other AKI etiologies
  • Compare evidence-based best practices for maintaining renal function and improving survival using different pharmacologic, interventional, and surgical treatment options in the management of HRS/AKI
  • Develop management plans for patients with AKI that incorporate interventions based on the evidence and etiology of disease, including bridging to transplantation in patients with HRS/AKI
Course summary
Available credit: 
  • 1.50 ABIM MOC
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Category I Credit for Physician Assistants
  • 1.50 ANCC Nurse Contact Hours
  • 0.75 ANCC Pharmacology
  • 1.50 Attendance
  • 1.50 ABTC Continuing Education Points
  • 1.50 ACPE Contact Hours
  • 1.50 ASWB Continuing Education Clock Hours
  • 1.50 CDR CPEUs
  • 1.50 ANCC Dialysis Technician Contact Hours
  • 0.75 AANP and ANCC Pharmacology
Course opens: 
08/10/2020
Course expires: 
08/10/2021
Cost:
$0.00
Rating: 
0
Faculty Disclosures:

Juan Carlos Velez, MD
Department Chair
Ochsner Health System
New Orleans, LA
Disclosure: Mallinckrodt, honoraria
Otsuka, honoraria

Ashita Tolwani, MD, MSc
Professor
University of Alabama at Birmingham
Birmingham, AL
Disclosure: Baxter Healthcare, honoraria 

Kevin Regner, MD, MS
Professor of Medicine
Medical College of Wisconsin
Milwaukee, WI
Disclosure: Malinckrodt Pharma, consulting fee

Planning Committee Disclosures:

Mark Perazella, MD
Professor of Medicine
Yale University School of Medicine
New Haven. CT
Disclosure: Has no financial relationships with commercial interest(s).

Mitchell Rosner, MD
Professor of Medicine
University of Virginia
Charlottesville, VA
Disclosure: Baxter Healthcare, honoraria

Erin Barreto, PharmD, MSc
Assistant Professor of Medicine and Pharmacy
Mayo Clinic
Rochester, MN
Disclosure: FAST Biomedical, consulting fee

Beth Morlang, RD, LDN, FNKF
Registered Dietitian
Central Florida Kidney Centers
Palm Bay, FL
Disclosure: Has no financial relationships with commercial interest(s).

Mary Lincoln, RN, BSN, MHA
Dialysis Director 
MercyOne
Clinton, IA
Disclosure: Has no financial relationships with commercial interest(s).

Gail Torres, RN, MS, RD
Senior Clinical Communications Director
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Jessica Joseph, MBA
Senior Vice President, Scientific Operations
National Kidney Foundation 
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Kathryn Troy, MPH
Senior Continuing Medical Education Manager
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Reviewer Disclosure:

Aldo Peixoto, MD
Professor of Medicine
Yale University
New Haven, CT
Disclosure: Grants: Bayer, Lundbeck, Vascular Dynamics; Honoraria: Ablative Solutions, Relypsa, DiaMedica

Samuel Silver, MD
Assistant Professor 
Queen's University
Kingston, Canada
Disclosure: Honoraria: Baxter

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

In support of improving patient care, the National Kidney Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician

The National Kidney Foundation designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)TMPhysicians should claim only the credit commensurate with the extent of their participation in the activity. 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurse Practitioner, Nurse and Dialysis Technician

Awarded 1.5 contact hours of continuing nursing education (includes 0.75 contact hours in the area of pharmacology).

Pharmacist

This knowledge-based enduring activity has been assigned Universal Activity Number JA0004461-0000-20-025-H01-P, for 1.5 contact hours (0.15 CEUs). To receive credit, learners must read the activity overview, learning objectives and faculty disclosures, complete the pre-test, review the content, complete the post-test with a minimum score of 70% (post-test may be taken up to 3 times) and electronic activity evaluation. An NABP eProfile ID and date of birth in MMDD format are prerequisites for receiving continuing pharmacy education credits. All credit awarded to participants must be uploaded to CPE Monitor™ within 30 days of the activity date, so pharmacists and pharmacy technicians are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity.  Please contact cmeinfo@kidney.org if you do not see activity information listed in your profile within 30 days.  For more information and to set up your e-Profile visit: www.MyCPEmonitor.net.

Physician Assistant


National Kidney Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until August 10, 2021. PAs should only claim credit commensurate with the extent of their participation.

Dietitian

The National Kidney Foundation is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR).  CDR Credentialed Practitioners will receive 1.5 Continuing Professional Education Units (CPEUs) for completion of this activity/material.


 

Social Worker

As a Jointly Accredited Organization, the National Kidney Foundation is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. The National Kidney Foundation maintains responsibility for this course. Social workers completing this course receive 1.5 continuing education credits.

Licensed social workers should contact their individual jurisdiction to review current continuing education requirements for licensure renewal.

Transplant Coordinator

The National Kidney Foundation is accredited as a provider of continuing transplant education by the American Board for Transplant Certification: CEPTC Provider Number #170. This activity has been granted 1.5 contact hours. Program ID 170-37. 

Available Credit

  • 1.50 ABIM MOC
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Category I Credit for Physician Assistants
  • 1.50 ANCC Nurse Contact Hours
  • 0.75 ANCC Pharmacology
  • 1.50 Attendance
  • 1.50 ABTC Continuing Education Points
  • 1.50 ACPE Contact Hours
  • 1.50 ASWB Continuing Education Clock Hours
  • 1.50 CDR CPEUs
  • 1.50 ANCC Dialysis Technician Contact Hours
  • 0.75 AANP and ANCC Pharmacology

Price

Cost:
$0.00
Please login or register for a PERC account to take this course.
 Disclaimer:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Required Hardware/software

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to CMEinfo@kidney.org or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit http://www.kidney.org/

For additional professional education resources, contact NKF at 1-800-622-9010 or visit https://www.kidney.org/professionals